KEGG ID/Pathway | # Proteins | FDR | KEGG ID/Pathway | # Proteins | FDR | KEGG ID/Pathway | # Proteins | FDR | |||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa05200 Pathways in cancer | 189 | 1.1E−30 | 31 | hsa05218 Melanoma | 36 | 1.4E−06 | 61 | hsa04360 Axon guidance | 66 | 3.2E−04 |
2 | hsa05215 Prostate cancer | 61 | 6.3E−20 | 32 | hsa04110 Cell cycle | 50 | 1.4E−06 | 62 | hsa05230 Central carbon metabolism in cancer | 29 | 4.6E−04 |
3 | hsa04151 PI3K-Akt signaling pathway | 136 | 8.6E−18 | 33 | hsa04390 Hippo signaling pathway | 57 | 1.5E−06 | 63 | hsa05168 Herpes simplex virus 1 infection | 86 | 5.1E−04 |
4 | hsa05203 Viral carcinogenesis | 86 | 1.8E−14 | 34 | hsa04066 HIF-1 signaling pathway | 43 | 2.1E−06 | 64 | hsa05160 Hepatitis C | 60 | 5.2E−04 |
5 | hsa04520 Adherens junction | 45 | 1.4E−13 | 35 | hsa05211 Renal cell carcinoma | 34 | 2.9E−06 | 65 | hsa04310 Wnt signaling pathway | 52 | 1.7E−03 |
6 | hsa04915 Estrogen signaling pathway | 66 | 2.9E−13 | 36 | hsa04921 Oxytocin signaling pathway | 61 | 3.5E−06 | 66 | hsa04370 VEGF signaling pathway | 27 | 2.2E−03 |
7 | hsa04540 Gap junction | 51 | 7.3E−13 | 37 | hsa04071 Sphingolipid signaling pathway | 48 | 4.3E−06 | 67 | hsa04668 TNF signaling pathway | 39 | 2.6E−03 |
8 | hsa05166 Human T cell leukemia virus 1 infection | 109 | 1.0E−12 | 38 | hsa04014 Ras signaling pathway | 77 | 6.3E−06 | 68 | hsa05219 Bladder cancer | 21 | 2.7E−03 |
9 | hsa04068 FoxO signaling pathway | 62 | 5.7E−12 | 39 | hsa04810 Regulation of actin cytoskeleton | 72 | 7.6E−06 | 69 | hsa04660 T cell receptor signaling pathway | 39 | 3.3E−03 |
10 | hsa04015 Rap1 signaling pathway | 89 | 6.2E−12 | 40 | hsa05213 Endometrial cancer | 30 | 7.9E−06 | 70 | hsa04920 Adipocytokine signaling pathway | 29 | 4.1E−03 |
11 | hsa04010 MAPK signaling pathway | 109 | 7.2E−12 | 41 | hsa04261 Adrenergic signaling in cardiomyocytes | 58 | 9.8E−06 | 71 | hsa05100 Bacterial invasion of epithelial cells | 31 | 4.8E−03 |
12 | hsa05161 Hepatitis B | 71 | 7.5E−12 | 42 | hsa05210 Colorectal cancer | 41 | 9.9E−06 | 72 | hsa04062 Chemokine signaling pathway | 59 | 5.0E−03 |
13 | hsa04510 Focal adhesion | 84 | 1.9E−11 | 43 | hsa05223 Non−small cell lung cancer | 35 | 1.2E−05 | 73 | hsa04914 Progesterone−mediated oocyte maturation | 34 | 7.0E−03 |
14 | hsa04022 cGMP-PKG signaling pathway | 72 | 1.9E−11 | 44 | hsa05231 Choline metabolism in cancer | 42 | 1.3E−05 | 74 | hsa04666 Fc gamma R-mediated phagocytosis | 33 | 9.0E−03 |
15 | hsa05220 Chronic myeloid leukemia | 43 | 8.6E−11 | 45 | hsa05202 Transcriptional misregulation in cancer | 61 | 1.3E−05 | 75 | hsa04911 Insulin secretion | 34 | 1.2E−02 |
16 | hsa05205 Proteoglycans in cancer | 80 | 1.1E−10 | 46 | hsa04550 Signaling pathways regulating pluripotency of stem cells | 53 | 1.7E−05 | 76 | hsa04720 Long-term potentiation | 29 | 1.3E−02 |
17 | hsa04919 Thyroid hormone signaling pathway | 56 | 2.0E−10 | 47 | hsa04730 Long-term depression | 32 | 1.8E−05 | 77 | hsa04918 Thyroid hormone synthesis | 30 | 1.4E−02 |
18 | hsa04725 Cholinergic synapse | 51 | 3.0E−09 | 48 | hsa05414 Dilated cardiomyopathy (DCM) | 43 | 1.9E−05 | 78 | hsa05145 Toxoplasmosis | 39 | 1.5E−02 |
19 | hsa04024 cAMP signaling pathway | 82 | 5.9E−09 | 49 | hsa04925 Aldosterone synthesis and secretion | 47 | 2.3E−05 | 79 | hsa04380 Osteoclast differentiation | 43 | 1.5E−02 |
20 | hsa05214 Glioma | 39 | 1.1E−08 | 50 | hsa04924 Renin secretion | 37 | 2.5E−05 | 80 | hsa04020 Calcium signaling pathway | 60 | 1.5E−02 |
21 | hsa04120 Ubiquitin mediated proteolysis | 60 | 6.3E−08 | 51 | hsa05410 Hypertrophic cardiomyopathy (HCM) | 40 | 2.9E−05 | 81 | hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 30 | 1.8E−02 |
22 | hsa05221 Acute myeloid leukemia | 33 | 6.7E−08 | 52 | hsa04916 Melanogenesis | 45 | 3.2E−05 | 82 | hsa04917 Prolactin signaling pathway | 29 | 1.9E−02 |
23 | hsa05222 Small cell lung cancer | 43 | 9.1E−08 | 53 | hsa04931 Insulin resistance | 45 | 3.8E−05 | 83 | hsa04922 Glucagon signaling pathway | 40 | 2.0E−02 |
24 | hsa04728 Dopaminergic synapse | 59 | 1.3E−07 | 54 | hsa04350 TGF-beta signaling pathway | 38 | 7.2E−05 | 84 | hsa04664 Fc epsilon RI signaling pathway | 28 | 2.4E−02 |
25 | hsa04012 ErbB signaling pathway | 41 | 2.2E−07 | 55 | hsa04114 Oocyte meiosis | 46 | 9.6E−05 | 85 | hsa04270 Vascular smooth muscle contraction | 48 | 2.8E−02 |
26 | hsa05212 Pancreatic cancer | 37 | 3.5E−07 | 56 | hsa05142 Chagas disease (American trypanosomiasis) | 43 | 1.2E−04 | 86 | hsa05130 Pathogenic Escherichia coli infection | 64 | 4.1E−02 |
27 | hsa05169 Epstein–Barr virus infection | 68 | 7.2E−07 | 57 | hsa04662 B cell receptor signaling pathway | 32 | 2.1E−04 | 87 | hsa04750 Inflammatory mediator regulation of TRP channels | 38 | 4.3E−02 |
28 | hsa05216 Thyroid cancer | 23 | 7.9E−07 | 58 | hsa04713 Circadian entrainment | 42 | 2.4E−04 | ||||
29 | hsa04912 GnRH signaling pathway | 46 | 1.2E−06 | 59 | hsa04144 Endocytosis | 75 | 2.9E−04 | hsa01100 Metabolic pathways | 140 | 1.00 + 02 | |
30 | hsa04722 Neurotrophin signaling pathway | 51 | 1.3E−06 | 60 | hsa04710 Circadian rhythm | 19 | 3.0E−04 |